81 FR 3442 - Solicitation of Nominations for Membership on the Secretary's Advisory Committee on Human Research Protections

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 81, Issue 13 (January 21, 2016)

Page Range		3442-3443
FR Document		2016-01049

The Office for Human Research Protections (OHRP), a program office in the Office of the Assistant Secretary for Health, Department of Health and Human Services (HHS), is seeking four (4) nominations of qualified candidates to be considered for appointment as members of the Secretary's Advisory Committee on Human Research Protections (SACHRP). SACHRP provides advice and recommendations to the Secretary, HHS, through the Assistant Secretary for Health on issues pertaining to the continuance and improvement of functions within the authority of HHS directed toward protections for human subjects in research. SACHRP was established by the Secretary, HHS, on October 1, 2002. OHRP is seeking nominations of four qualified candidates to fill positions on the Committee membership that will be vacated during the 2016 calendar year, including the position of Chair.

Federal Register, Volume 81 Issue 13 (Thursday, January 21, 2016)

[Federal Register Volume 81, Number 13 (Thursday, January 21, 2016)]
[Notices]
[Pages 3442-3443]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-01049]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Solicitation of Nominations for Membership on the Secretary's 
Advisory Committee on Human Research Protections

AGENCY: Office for Human Research Protections, Office of the Secretary, 
Office of the Assistant Secretary for Health, Department of Health and 
Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

    Authority: 42 U.S.C. 217a, Section 222 of the Public Health 
Service Act, as amended. The Committee is governed by the provisions 
of Public Law 92-463, as amended (5 U.S.C. Appendix 2), which sets 
forth standards for the formation and use of advisory committees.

SUMMARY: The Office for Human Research Protections (OHRP), a program 
office in the Office of the Assistant Secretary for Health, Department 
of Health and Human Services (HHS), is seeking four (4) nominations of 
qualified candidates to be considered for appointment as members of the 
Secretary's Advisory Committee on Human Research Protections (SACHRP). 
SACHRP provides advice and recommendations to the Secretary, HHS, 
through the Assistant Secretary for Health on issues pertaining to the 
continuance and improvement of functions within the authority of HHS 
directed toward protections for human subjects in research. SACHRP was 
established by the Secretary, HHS, on October 1, 2002. OHRP is seeking 
nominations of four qualified candidates to fill positions on the 
Committee membership that will be vacated during the 2016 calendar 
year, including the position of Chair.

DATES: Nominations for membership on the Committee must be received no 
later than March 21, 2016.

ADDRESSES: Nominations should be mailed or delivered to Julia Gorey, 
Executive Director, SACHRP, Office for Human Research Protections, 
Department of Health and Human Services, 1101 Wootton Parkway, Suite 
200; Rockville, MD 20852. Nominations will not be accepted by email or 
by facsimile.

FOR FURTHER INFORMATION CONTACT: Julia Gorey, Executive Director, 
SACHRP, Office for Human Research Protections, 1101 Wootton Parkway, 
Suite 200, Rockville, MD 20852, telephone: 240-453-8141. A copy of the 
Committee charter and list of the current members can be obtained by 
accessing the SACHRP Web site at www.hhs.gov/ohrp/sachrp, or requesting 
via email at [email protected].

SUPPLEMENTARY INFORMATION: The Committee provides advice on matters 
pertaining to the continuance and improvement of functions within the 
authority of HHS directed toward protections for human subjects in 
research. Specifically, the Committee provides advice relating to the 
responsible conduct of research involving human subjects with 
particular emphasis on special populations such as neonates and 
children, prisoners, the decisionally impaired, pregnant women, embryos 
and fetuses, individuals and populations in international studies, 
investigator conflicts of interest and populations in which there are 
individually identifiable samples, data or information.
    In addition, the Committee is responsible for reviewing selected 
ongoing work and planned activities of the OHRP and other offices/
agencies within HHS responsible for human subjects protection. These 
evaluations may include, but are not limited to, issues relating to the 
Notice of Proposed Rulemaking (NPRM) titled ``Federal Policy for the 
Protection of Human Subjects'' that appeared in the Federal Register on 
September 8, 2015, Vol 80, No 173:53933. In addition, SACHRP may review 
matters pertaining to the assurance system, the application of minimal 
research risk standards, the granting of waivers, education programs 
sponsored by OHRP, and the ongoing monitoring and oversight of 
institutional review boards and the institutions that sponsor research.
    Nominations: The OHRP is requesting nominations to fill four (4) 
positions for voting members of SACHRP that will become vacant in 
October 2016. Nominations of potential candidates for consideration are 
being sought from a wide array of fields, including, but not limited 
to: Public health and medicine, behavioral and social sciences, health 
administration, and biomedical ethics. To qualify for consideration of 
appointment to the Committee, an individual must possess demonstrated 
experience and expertise in any of the several disciplines and fields 
pertinent to human subjects protection and/or clinical research, as 
well as the necessary time and dedication to devote to responsible 
membership on a working federal advisory committee.
    The individuals selected for appointment to the Committee may be 
invited to serve a term of up to four years. Committee members receive 
a stipend and reimbursement for per diem and any travel expenses 
incurred for attending Committee meetings and/or conducting other 
business in the interest of the Committee. Interested applicants may 
self-nominate. Nominations may be retained and considered for future 
vacancies.
    Nominations should be typewritten. The following information should 
be included in the package of material submitted for each individual 
being nominated for consideration: (1) A letter of nomination that 
clearly states the name and affiliation of the nominee, the basis for 
the nomination (i.e., specific attributes which qualify the nominee for 
service in this capacity), and a statement that the nominee is willing 
to serve as a member of the Committee; (2) the nominator's name, 
address, daytime telephone number and the home and/or work address, 
telephone number, and email address of the individual being nominated; 
and (3) a current copy of the nominee's curriculum vitae. Federal 
employees should not be nominated for consideration of appointment to 
this Committee.
    The Department makes every effort to ensure that the membership of 
HHS federal advisory committees is fairly balanced in terms of points 
of view represented and the committee's function. Every effort is made 
to ensure that individuals from a broad representation of geographic 
areas, women and men, ethnic and minority groups, and the disabled are 
given consideration for membership on HHS federal advisory committees. 
Appointment to this Committee shall be made without discrimination on 
the basis of age, race, ethnicity, gender, sexual orientation, 
disability, and cultural, religious, or socioeconomic status.
    Individuals who are selected to be considered for appointment will 
be required to provide detailed information regarding their financial 
holdings, consultancies, and research grants or contracts. Disclosure 
of this information is necessary in order to determine if the

[[Page 3443]]

selected candidate is involved in any activity that may pose a 
potential conflict with the official duties to be performed as a member 
of SACHRP.

    Dated: January 14, 2016.
Julia Gorey,
Executive Director, Secretary's Advisory Committee on Human Research 
Protections.
[FR Doc. 2016-01049 Filed 1-20-16; 8:45 am]
BILLING CODE 4150-36-P

Federal Register / Vol. 81, No. 13 / Thursday, January 21, 2016 / Notices 3443

selected candidate is involved in any Cancer Institute, 9609 Medical Center Drive, Dated: January 14, 2016.
activity that may pose a potential Room 7W238, Bethesda, Md 20892–9750, Melanie J. Gray,
conflict with the official duties to be 240–276–6371, decluej@mail.nih.gov. Program Analyst, Office of Federal Advisory
performed as a member of SACHRP. Name of Committee: National Cancer Committee Policy.
Dated: January 14, 2016. Institute Special Emphasis Panel; NCI [FR Doc. 2016–01068 Filed 1–20–16; 8:45 am]
Julia Gorey, Omnibus SEP–6. BILLING CODE 4140–01–P
Date: March 7–8, 2016.
Executive Director, Secretary’s Advisory
Time: 8:00 a.m. to 2:00 p.m.
Committee on Human Research Protections.
Agenda: To review and evaluate grant DEPARTMENT OF HEALTH AND
[FR Doc. 2016–01049 Filed 1–20–16; 8:45 am]
applications. HUMAN SERVICES
BILLING CODE 4150–36–P
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW., National Institutes of Health
Washington, DC 20015.
DEPARTMENT OF HEALTH AND Contact Person: Dona Love, Ph.D., Center for Scientific Review; Notice of
HUMAN SERVICES Scientific Review Officer, Special Review Closed Meetings
National Institutes of Health Branch, Division of Extramural Activities,
Pursuant to section 10(d) of the
National Cancer Institute, NIH, 9609 Medical
Federal Advisory Committee Act, as
National Cancer Institute; Notice of Center Drive, 7W236, Rockville, MD 20850,
amended (5 U.S.C. App.), notice is
Closed Meetings 240–276–5264, donalove@mail.nih.gov.
hereby given of the following meetings.
Name of Committee: National Cancer The meetings will be closed to the
Pursuant to section 10(d) of the Institute Special Emphasis Panel;
Federal Advisory Committee Act, as public in accordance with the
Outstanding Investigator Award I.
amended (5 U.S.C. App.), notice is provisions set forth in sections
Date: March 22–24, 2016.
hereby given of the following meetings. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Time: 6:00 p.m. to 5:00 p.m.
The meetings will be closed to the as amended. The grant applications and
Agenda: To review and evaluate grant
public in accordance with the the discussions could disclose
applications.
provisions set forth in sections confidential trade secrets or commercial
Place: Gaithersburg Marriott
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., property such as patentable material,
Washingtonian Center, 9751 Washingtonian
as amended. The grant applications and Boulevard, Gaithersburg, MD 20878.
and personal information concerning
the discussions could disclose Contact Person: Michael B. Small, Ph.D.,
individuals associated with the grant
confidential trade secrets or commercial Chief, Program and Review Extramural Staff applications, the disclosure of which
property such as patentable material, Training Office, Division of Extramural would constitute a clearly unwarranted
and personal information concerning Activities, National Cancer Institute, NIH, invasion of personal privacy.
individuals associated with the grant 9609 Medical Center Drive, Room 7W412, Name of Committee: Endocrinology,
applications, the disclosure of which Rockville, MD 20850, 240–276–6438, Metabolism, Nutrition and Reproductive
would constitute a clearly unwarranted smallm@mail.nih.gov. Sciences Integrated Review Group—Cellular
invasion of personal privacy. Aspects of Diabetes and Obesity Study
Name of Committee: National Cancer
Section.
Name of Committee: National Cancer Institute Special Emphasis Panel; Date: February 9–10, 2016.
Institute Special Emphasis Panel; Outstanding Investigator Award II. Time: 8:00 a.m. to 3:00 p.m.
Quantitative Imaging for Evaluation of Date: March 22–24, 2016. Agenda: To review and evaluate grant
Response to Cancer Therapies (U01). Time: 6:00 p.m. to 5:00 p.m. applications.
Date: February 25, 2016. Agenda: To review and evaluate grant Place: Residence Inn Bethesda, 7335
Time: 1:00 p.m. to 4:00 p.m.
applications. Wisconsin Avenue, Bethesda, MD 20814.
Agenda: To review and evaluate grant
Place: Gaithersburg Marriott Contact Person: Antonello Pileggi, MD,
applications.
Washingtonian Center, 9751 Washingtonian Ph.D., Scientific Review Officer, Center for
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room Boulevard, Gaithersburg, MD 20878. Scientific Review, National Institute of
5W030, Rockville, MD 20850, (Telephone Contact Person: Shamala K. Srinivas, Health, 6701 Rockledge Drive, Room 6166,
Conference Call). Ph.D., Scientific Review Officer, Office of Bethesda, MD 20892–7892, (301) 402–6297,
Contact Person: Gerald G. Lovinger, Ph.D., Referral, Review, and Program Coordination, pileggia@csr.nih.gov.
Scientific Review Officer, Research Division of Extramural Activities, National Name of Committee: Biological Chemistry
Technology and Contract Review Branch, Cancer Institute, NIH, 9609 Medical Center and Macromolecular Biophysics Integrated
Division of Extramural Activities, National Drive, Room 7W530, Bethesda, MD 20892– Review Group—Macromolecular Structure
Cancer Institute, 9609 Medical Center Drive, and Function A Study Section.
8328, 240–276–6442, ss537t@nih.gov,
Room 7W266, Bethesda, MD 20892–9750, Date: February 11–12, 2016.
240–276–6385, lovingeg@mail.nih.gov. Information is also available on the Time: 8:00 a.m. to 5:00 p.m.
Name of Committee: National Cancer Institute’s/Center’s home page: http:// Agenda: To review and evaluate grant
Institute Special Emphasis Panel; deainfo.nci.nih.gov/advisory/sep/sep.htm, applications.
Technologies for Cancer-Relevant where an agenda and any additional Place: Serrano Hotel, 405 Taylor Street,
Biospecimen Science. information for the meeting will be posted San Francisco, CA 94102.
Date: March 2, 2016. when available. Contact Person: Nitsa Rosenzweig, Ph.D.,
Time: 11:00 a.m. to 5:00 p.m. Scientific Review Officer, Center for
(Catalogue of Federal Domestic Assistance
Agenda: To review and evaluate grant Scientific Review, National Institutes of
asabaliauskas on DSK9F6TC42PROD with NOTICES

Program Nos. 93.392, Cancer Construction; Health, 6701 Rockledge Drive, Room 4152,
applications. 93.393, Cancer Cause and Prevention
Place: National Cancer Institute Shady MSC 7760, Bethesda, MD 20892, (301) 404–
Research; 93.394, Cancer Detection and 7419, rosenzweign@csr.nih.gov.
Grove, 9609 Medical Center Drive, Room
2W904, Rockville, MD 20850, (Telephone Diagnosis Research; 93.395, Cancer Name of Committee: Healthcare Delivery
Conference Call). Treatment Research; 93.396, Cancer Biology and Methodologies Integrated Review
Contact Person: Jeffrey E. DeClue, Ph.D., Research; 93.397, Cancer Centers Support; Group—Community Influences on Health
Scientific Review Officer, Research 93.398, Cancer Research Manpower; 93.399, Behavior Study Section.
Technology and Contract Review Branch, Cancer Control, National Institutes of Health, Date: February 11–12, 2016.
Division Of Extramural Activities, National HHS) Time: 8:00 a.m. to 5:00 p.m.

VerDate Sep<11>2014 18:26 Jan 20, 2016 Jkt 238001 PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 E:\FR\FM\21JAN1.SGM 21JAN1

Document Created: 2018-02-02 12:34:08
Document Modified: 2018-02-02 12:34:08

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice.
Dates		Nominations for membership on the Committee must be received no later than March 21, 2016.
Contact		Julia Gorey, Executive Director, SACHRP, Office for Human Research Protections, 1101 Wootton Parkway, Suite 200, Rockville, MD 20852, telephone: 240-453-8141. A copy of the Committee charter and list of the current members can be obtained by accessing the SACHRP Web site at www.hhs.gov/ohrp/sachrp, or requesting via email at [email protected]
FR Citation		81 FR 3442